Matches in SemOpenAlex for { <https://semopenalex.org/work/W1797564887> ?p ?o ?g. }
- W1797564887 endingPage "61" @default.
- W1797564887 startingPage "6353" @default.
- W1797564887 abstract "Chemoimmunotherapy has been used to treat intrahepatic cholangiocarcinoma (ICC). However, little is known about the phenomena underlying the immunomodulation of ICC cells elicited by chemoimmunotherapy.Primary ICC cells from a patient with ICC who received gemcitabine followed by 5-fluorouracil (5-FU), both combined with dendritic cells pulsed with Wilms' tumor 1 (WT1) peptides were cultured. ICC cells were treated with gemcitabine, 5-FU or interferon (IFN)-γ in vitro. The phenotype of the ICC cells was examined by flow cytometry and quantitative reverse transcription polymerase chain reaction.Stimulation of the ICC cells with gemcitabine resulted in up-regulation of WT1 mRNA, programmed death receptor ligand-1 (PDL1) and calreticulin. Gemcitabine, 5-FU and IFN-γ induced up-regulation of mucin-1. Moreover, human leukocyte antigen (HLA)-ABC, HLA-DR and PDL1 were extremely up-regulated by IFN-γ.Chemoimmunomodulating agents alter the immunogenicity of ICC cells, resulting in complex clinical efficacy results." @default.
- W1797564887 created "2016-06-24" @default.
- W1797564887 creator A5003016176 @default.
- W1797564887 creator A5021069937 @default.
- W1797564887 creator A5025411183 @default.
- W1797564887 creator A5039762495 @default.
- W1797564887 creator A5042761112 @default.
- W1797564887 creator A5051763064 @default.
- W1797564887 creator A5052816406 @default.
- W1797564887 creator A5053347778 @default.
- W1797564887 creator A5056411544 @default.
- W1797564887 creator A5059406298 @default.
- W1797564887 creator A5062795615 @default.
- W1797564887 creator A5070590061 @default.
- W1797564887 creator A5074025359 @default.
- W1797564887 creator A5076025317 @default.
- W1797564887 creator A5078965572 @default.
- W1797564887 creator A5082679580 @default.
- W1797564887 creator A5086577428 @default.
- W1797564887 date "2014-11-01" @default.
- W1797564887 modified "2023-10-07" @default.
- W1797564887 title "Immunogenic modulation of cholangiocarcinoma cells by chemoimmunotherapy." @default.
- W1797564887 cites W1480342889 @default.
- W1797564887 cites W1986081674 @default.
- W1797564887 cites W1999998145 @default.
- W1797564887 cites W2016612145 @default.
- W1797564887 cites W2028376975 @default.
- W1797564887 cites W2030676407 @default.
- W1797564887 cites W2032229065 @default.
- W1797564887 cites W2032626834 @default.
- W1797564887 cites W2035772974 @default.
- W1797564887 cites W2039395562 @default.
- W1797564887 cites W2057893793 @default.
- W1797564887 cites W2062024852 @default.
- W1797564887 cites W2080387155 @default.
- W1797564887 cites W2081566357 @default.
- W1797564887 cites W2090750060 @default.
- W1797564887 cites W2093424661 @default.
- W1797564887 cites W2101653483 @default.
- W1797564887 cites W2107043016 @default.
- W1797564887 cites W2117357598 @default.
- W1797564887 cites W2152831411 @default.
- W1797564887 cites W2161558877 @default.
- W1797564887 cites W2161585699 @default.
- W1797564887 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25368235" @default.
- W1797564887 hasPublicationYear "2014" @default.
- W1797564887 type Work @default.
- W1797564887 sameAs 1797564887 @default.
- W1797564887 citedByCount "17" @default.
- W1797564887 countsByYear W17975648872015 @default.
- W1797564887 countsByYear W17975648872016 @default.
- W1797564887 countsByYear W17975648872017 @default.
- W1797564887 countsByYear W17975648872018 @default.
- W1797564887 countsByYear W17975648872019 @default.
- W1797564887 countsByYear W17975648872022 @default.
- W1797564887 countsByYear W17975648872023 @default.
- W1797564887 crossrefType "journal-article" @default.
- W1797564887 hasAuthorship W1797564887A5003016176 @default.
- W1797564887 hasAuthorship W1797564887A5021069937 @default.
- W1797564887 hasAuthorship W1797564887A5025411183 @default.
- W1797564887 hasAuthorship W1797564887A5039762495 @default.
- W1797564887 hasAuthorship W1797564887A5042761112 @default.
- W1797564887 hasAuthorship W1797564887A5051763064 @default.
- W1797564887 hasAuthorship W1797564887A5052816406 @default.
- W1797564887 hasAuthorship W1797564887A5053347778 @default.
- W1797564887 hasAuthorship W1797564887A5056411544 @default.
- W1797564887 hasAuthorship W1797564887A5059406298 @default.
- W1797564887 hasAuthorship W1797564887A5062795615 @default.
- W1797564887 hasAuthorship W1797564887A5070590061 @default.
- W1797564887 hasAuthorship W1797564887A5074025359 @default.
- W1797564887 hasAuthorship W1797564887A5076025317 @default.
- W1797564887 hasAuthorship W1797564887A5078965572 @default.
- W1797564887 hasAuthorship W1797564887A5082679580 @default.
- W1797564887 hasAuthorship W1797564887A5086577428 @default.
- W1797564887 hasConcept C126322002 @default.
- W1797564887 hasConcept C147483822 @default.
- W1797564887 hasConcept C203014093 @default.
- W1797564887 hasConcept C207936829 @default.
- W1797564887 hasConcept C2775890610 @default.
- W1797564887 hasConcept C2776694085 @default.
- W1797564887 hasConcept C2777701055 @default.
- W1797564887 hasConcept C2778814158 @default.
- W1797564887 hasConcept C2780258809 @default.
- W1797564887 hasConcept C2780790343 @default.
- W1797564887 hasConcept C502942594 @default.
- W1797564887 hasConcept C553184892 @default.
- W1797564887 hasConcept C71924100 @default.
- W1797564887 hasConcept C86803240 @default.
- W1797564887 hasConcept C8891405 @default.
- W1797564887 hasConceptScore W1797564887C126322002 @default.
- W1797564887 hasConceptScore W1797564887C147483822 @default.
- W1797564887 hasConceptScore W1797564887C203014093 @default.
- W1797564887 hasConceptScore W1797564887C207936829 @default.
- W1797564887 hasConceptScore W1797564887C2775890610 @default.
- W1797564887 hasConceptScore W1797564887C2776694085 @default.
- W1797564887 hasConceptScore W1797564887C2777701055 @default.
- W1797564887 hasConceptScore W1797564887C2778814158 @default.
- W1797564887 hasConceptScore W1797564887C2780258809 @default.